Evolving Class of Drugs Advances Treatment for Autoimmune Disorders | UCLA Vital Signs
2,391 views · Published 30 June 2016 · 2:40 · Indexed 12 November 2026
Channel: UCLA Health · 2016 · Science & Technology
Meet Carly, whose treatment for rheumatoid arthritis has evolved dramatically in recent years due the growing availability of biologic therapies. Biologics are genetically engineered drugs designed to interact with the body’s immune response to dampen the damaging effects of rheumatologic disorders. Dr. Veena Ranganath comments more in Vital Signs at http://ucla.in/29P3VwM
More from this channel
-
8:59
UCLA Med Ctr Participates in Military Disaster Drill
-
4:39
Operation Mend Partnership Between UCLA and Brooke Army Med
-
3:07
UCLA Quilt of Valor | Operation Mend
-
3:37
Routine HIV Testing Recommended for Teens and Older
-
4:29
Kidney Donor Chain
-
3:39
Focus on LASIK - UCLA Laser Refractive Center
-
3:12
Mattel Children's Hospital UCLA Holiday Cards
-
3:06
TTCF 2009 Award Recipient | Mattel Children's Hospital UCLA